Changchun High-Tech Industry (Group) Co., Ltd. Share Price
Equities
000661
CNE0000007J8
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.80 CNY | -0.78% |
|
-0.20% | +2.37% |
| 07-03 | Changchun High-Tech Gets Chinese Market Launch Approval for Gout Treatment | MT |
| 06-20 | Changchun High-Tech Gets China Approval for Elderly Flu Vaccine Clinical Trial | MT |
| Capitalization | 41.02B 5.71B 4.9B 4.57B 4.25B 7.84B 492B 8.75B 55.18B 20.83B 231B 21.43B 20.99B 848B | P/E ratio 2025 * |
16.8x | P/E ratio 2026 * | 15.2x |
|---|---|---|---|---|---|
| Enterprise value | 41.02B 5.71B 4.9B 4.57B 4.25B 7.84B 492B 8.75B 55.18B 20.83B 231B 21.43B 20.99B 848B | EV / Sales 2025 * |
2.98x | EV / Sales 2026 * | 2.81x |
| Free-Float |
68.28% | Yield 2025 * |
2.49% | Yield 2026 * | 2.52% |
More valuation ratios
* Estimated data
More news
| 1 day | -0.78% | ||
| 1 week | -0.20% | ||
| Current month | +2.64% | ||
| 1 month | -1.26% | ||
| 3 months | +10.71% | ||
| 6 months | +8.94% | ||
| Current year | +2.37% |
| 1 week | 98.6 |  | 103.3 |
| 1 month | 96.36 | | 110.5 |
| Current year | 83 | | 113.67 |
| 1 year | 77.5 | | 125.78 |
| 3 years | 77.5 | | 238.5 |
| 5 years | 77.5 | | 523 |
| 10 years | 40.45 | | 523 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Jin
CEO | Chief Executive Officer | 60 | 10/09/2024 |
Xing Gong Zhu
DFI | Director of Finance/CFO | 58 | 24/05/2005 |
Peng Ye
PRN | Corporate Officer/Principal | 58 | 22/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhi Gang Wang
BRD | Director/Board Member | 53 | 28/12/2014 |
Yun Tao Jiang
CHM | Chairman | 51 | - |
Xian Chao Zhu
BRD | Director/Board Member | 60 | 27/03/2019 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 1.17% | 0 M€ | -19.71% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.78% | -0.20% | +7.29% | -51.25% | 5.71B | ||
| +3.62% | +6.83% | -17.27% | -13.24% | 81.33B | ||
| -1.36% | -4.44% | -49.17% | -7.53% | 57.33B | ||
| -1.78% | +5.10% | +23.65% | +29.75% | 53.86B | ||
| +0.49% | +2.28% | +27.49% | +106.34% | 38.73B | ||
| -0.06% | +10.55% | +118.53% | +146.33% | 19.4B | ||
| +0.31% | +11.62% | +86.31% | +820.19% | 18.86B | ||
| -2.88% | -6.87% | -44.51% | -41.69% | 18.31B | ||
| -0.04% | -.--% | +75.97% | +143.35% | 14.02B | ||
| -1.57% | -1.06% | +3.81% | -13.95% | 13.14B | ||
| Average | +0.10% | +2.04% | +23.21% | +111.83% | 32.07B | |
| Weighted average by Cap. | +0.63% | +2.25% | +7.43% | +72.62% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 13.77B 1.92B 1.65B 1.53B 1.43B 2.63B 165B 2.94B 18.53B 6.99B 77.47B 7.2B 7.05B 285B | 14.57B 2.03B 1.74B 1.62B 1.51B 2.79B 175B 3.11B 19.6B 7.4B 81.96B 7.61B 7.46B 301B |
| Net income | 2.44B 340M 291M 271M 253M 466M 29.24B 520M 3.28B 1.24B 13.71B 1.27B 1.25B 50.4B | 2.7B 377M 323M 301M 280M 517M 32.44B 577M 3.64B 1.37B 15.21B 1.41B 1.38B 55.9B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
11,547
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/07/25 | 101.80 ¥ | -0.78% | 5,581,800 |
| 17/07/25 | 102.60 ¥ | +3.19% | 9,301,426 |
| 16/07/25 | 99.43 ¥ | +0.01% | 4,191,142 |
| 15/07/25 | 99.42 ¥ | -1.24% | 6,923,755 |
| 14/07/25 | 100.67 ¥ | -1.30% | 5,438,300 |
End-of-day quote Shenzhen S.E., July 17, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
101.80CNY
Average target price
107.16CNY
Spread / Average Target
+5.27%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 000661 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition